Meet our Research Team!

Welcome to MISSION RESEARCH INSTITUTE
Our Mission Statement
Mission Research strives to provide the highest quality care and the highest standards for our research patients. Participation in clinical trails allows our patients access to the latest research and treatment development.
Clinical Research provides quality, clinical research with the highest standards for patient safety.
Mission Research Institute works with top pharmaceutical companies to conduct Phase II-IV clinical research studies in central Texas. Participation in clinical trials allows access to the latest research treatment developments. Mission Research Institute continues to bring you the most promising therapies of the future.
What is a Clinical Trial?
A clinical trial (part of clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted, clinical trials are the fastest and safest way to find treatments that work in people and to contribute to medical research.
Current Studies
Participants in clinical trials can play a more active role in their own healthcare, gain access to new research treatments before they are widely available, and help others by contributing to medical research. We have many ongoing clinical trials to treat a number of ailments including Device Studies, High Cholesterol, Peripheral Artery Disease, and Hypertension.
Hospital Affiliations:
CHRISTUS Santa Rosa Hospital – New Braunfels
600 N Union Ave
(830) 606-9111
Resolute Health Hospital
555 Creekside Crossing
(830) 500-6000
Guadalupe Regional Medical Center
1215 E Court St
(830) 379-2411
Mission Cardiac and Vascular institue
4.0 (1) · Doctor
479 Oxford #104
Research Committee:
Frank Rubalcava, MD
Yasser Farra, DO, PharmD
Jamison Wyatt, MD
Michael Benca, MD
Rahul Bose, MD
Clinical Staff:
Hollilyn Miska, MA, CRC
Traci Spivey, LVN, Lead CRC
Research Experience:
2/2019 SOLOIST: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter study to evaluate the effects of SOtagLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST worsening Heart Failure
1/2019 ILLUMENTE BTK: Stellar 0.014 OTW Drug-coated (paclitaxel-coated) angioplasty (Prx PTA) ballon catheter, provided in diameters ranging from 2-4mm and lenghs up to 150mm
11/2018 AEGIS-II: A Phase 3 Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel group study to investigate the efficacy and safety of CSL112 in subjects with Acute Coronary Syndrome.
5/2018 APPRAISE ATP: Assessment of Primary Prevention Patients receiving an ICD- Systematic
Evaluation of ATP
5/2018 CONNECT: Care Optimization through Patient and Hospital Engagement Clinical Trial for
Heart Failure
1/2018 CHOCOLATE TOUCH: Study to assess the Drug-Coated Chocolate Touch Balloon Catheter’s safety and effectiveness compared to an FDA approved drug-coated balloon.
7/2017 TOBA II BTK: Tack Optimized Balloon Angioplasty Study for the Below The Knee Arteries Using the Tack Endovascular System
4/2017 ZOLL: WCD Regisrty And Study Of Patient Care Over A Year Period After Use Of WCD
1/2017 AWAKE: Study on the effects of sacubitril/valsartan on physical activity and sleep in heart failure with reduced ejection fraction patients.
11/2016 TOBA II: Tack Optimized Balloon Angioplasty Study for the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System.
6/2016 LIMBO:Lower-Limb Adentital Infusion of Dexamethsone Via Bullfrog to Reduce Occurrence Of Restenosis After Atherectomy Revascularization
3/2016 CHAMP: Observational Registry Of Treatment Patterns In U.S Heart Failure Patients With Reduce
Ejection Faction
8/2015 UPSTREAM: Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment
Elevation Acute Coronary Syndrome (An ED-Based Clinical Registry)
7/2015 MIMICS-2: Evaluation of Safety and Effectiveness of the BioMimics 3D™ Stent System in the Femoropopliteal Arteries of Patients with Symptomatic Peripheral Arterial Disease
7/2015 EXCITE: Excimer Laser Randomized Controlled Study for Evaluation of Femoropopliteal
In-stent Restenosis
5/2015 DANCE PARTNER: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and
Treatment Outcomes
4/2015 ARTEMIS: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial
Infarction Study
4/2015 REDUCE-IT: Reduction Of Cardiovascular Events With EPA- Intervention Trail
12/2014 ANTELOPE: An Assessment of The Glider Balloon in Complex Lesions
12/2014 ABLATE: Atherectomy by Laser Ablation with Turbo Elite
10/2014 PLATINUM DIVERSITY: Outcomes with the Promus Premier
7/2014 LIBERTY 360: To evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease
5/2014 DANCE: Delivery of Dexamethasone to the Adventitia to Enhance Clinical Efficacy after Femoropopliteal Revascularization
7/2013 MACE : Multi-center Prospective Study to Evaluate Outcomes of Moderate to Severely Calcified
6/2013 LEVANT 2: A Prospective, Mulitcenter, Registry of the Lutonix Drug Coated Balloon for Treatment of
Femoropopliteal Arteries
2/2013 CLARITY I: Complete Lesion Assessment with ffR and Ivus TechnologY
12/2012 GLORIA-AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with
Atrial Fibrillation